QIAGEN NV : Gets a Buy rating from Jefferies
0f975e62.p2CCASbIr2z_VoIkQavoTjGpNwkTs05s0M-frfj0bbA.z1jvVkCa1lW1GvdOCN-4O1DiQ3NL2AIZ_Yyv2rqgOPPKEvRFQPDhXLoa4Q
Create an account
Continue with Google
Continue with Apple
Continue with LinkedIn
or by email
Continue with an email
Create an account with Google
Create an account with Apple
Create an account with LinkedIn
or by email
Create an account
Enter your password
ContinueForgot your password ?
Top Capitalization United States North America
Middle East Sector Research Company calendar Equities Analysis
Most popular VERIZON COMMUNICATIONS, INC. MICROSOFT CORPORATION NVIDIA CORPORATION SALESFORCE, INC. MERCK & CO., INC. AMAZON.COM, INC. ELI LILLY AND COMPANY
Index Analysis Indices News
EURO STOXX 50
Currency / Forex
Currency Cross Rate Currency Converter Forex Analysis Currencies News
Commodities
Precious metals Agriculture Industrial Metals Livestock and Cattle
CRUDE OIL (WTI) CRUDE OIL (BRENT)
Cryptocurrencies
BINANCE COIN
Interest Rates
Yield Curve Developed Nations Emerging Countries
Macroeconomics
Geopolitics
International Trade Military conflicts
Sustainable development Legal, Regulation and Crime
Financial Results Analyst Recommendations Transcripts Press releases Insider transaction Controversies Innovations and expansions
Negative surprises Positive surprises New Contracts
Currency / Forex
Commodities
Cryptocurrencies
Interest Rates
Most Read News
Business Insiders
All Articles
Equities Analysis
Commodities
Cryptocurrencies
Stock Trading Strategies
Economic calendar
Company calendar
Dividend calendar Stock Picks
All our investments
United States
Asia, Pacific
USA Portfolio
European Portfolio
Asian Portfolio
Virtual Portfolios
My Watchlists
My previous session My most visited Most popular
Investment Style
Undervalued stocks Quality stocks Low volatility Multibaggers Growth stocks at reasonable prices Monthly dividends
Investment Themes
Private Equity Biotechnology
Short-Term Gainers & Losers Long-term Gainers & Losers Unusual volumes New Historical Highs New Historical Lows
Top Fundamentals
Fundamental Composite Sales growth Earnings Growth Profitability
Rankings Valuation
Valuation Composite Capitalization
Enterprise value
Price to Book (PBR) Free Cash Flow (FCF)
Top Consensus
Consensus composite Analyst Opinion Target price Opinion Divergences Estimates Revisions Analyst coverage
Technical Analysis Rankings
Daily Breakouts Weekly Breakouts
Top ranking ESG
Environment
Islamic Finance Paris Agreement
Stock Screener Home
Investment Themes
The Vegan Market Private Equity
Place your bets Gold and Silver
Technical Rankings
Oversold stocks Overbought stocks Close to resistance Close to support Accumulation Phases Most volatile stocks
Fundamental Rankings
Top Investor Rating Top Trading Rating Top Consensus
Top Dividends Low valuations
My Screeners
All my stocks
Virtual Portfolios
MarketScreener tools
Stock Screener
Expert tools
Stock Screener PRO Portfolio Creator Event Screener
Dynamic Chart
Company calendar
Economic calendar
Currency Converter Our Services
Our subscriptions
Our Stock Picks
Stock Screener
Thematic Investment Lists
MarketScreener Portfolios
European Portfolio USA Portfolio Asian Portfolio
Top Capitalization United States North America
Middle East Sector Research Company calendar Equities Analysis Most popular VERIZON COMMUNICATIONS, INC. MICROSOFT CORPORATION NVIDIA CORPORATION SALESFORCE, INC. MERCK & CO., INC. AMAZON.COM, INC. ELI LILLY AND COMPANY
Index Analysis Indices News
EURO STOXX 50
Currency / Forex
Currency Cross Rate Currency Converter Forex Analysis Currencies News
Commodities
Precious metals Agriculture Industrial Metals Livestock and Cattle
CRUDE OIL (WTI) CRUDE OIL (BRENT)
Cryptocurrencies
BINANCE COIN
Interest Rates
Yield Curve Developed Nations Emerging Countries
Macroeconomics
Geopolitics
International Trade Military conflicts
Sustainable development Legal, Regulation and Crime
Financial Results Analyst Recommendations Transcripts Press releases Insider transaction Controversies Innovations and expansions
Negative surprises Positive surprises New Contracts
Currency / Forex Commodities Cryptocurrencies
Interest Rates
Most Read News
Business Insiders
All Articles
Equities Analysis
Commodities
Cryptocurrencies Stock Trading Strategies
Economic calendar Company calendar Dividend calendar
Stock Picks
All our investments United States
Asia, Pacific
USA Portfolio European Portfolio Asian Portfolio Virtual Portfolios
My Watchlists
My previous session My most visited Most popular
Investment Style
Undervalued stocks Quality stocks Low volatility Multibaggers Growth stocks at reasonable prices Monthly dividends
Investment Themes
Private Equity Biotechnology
Short-Term Gainers & Losers Long-term Gainers & Losers Unusual volumes New Historical Highs New Historical Lows
Top Fundamentals
Fundamental Composite Sales growth Earnings Growth Profitability
Rankings Valuation
Valuation Composite Capitalization
Enterprise value
Price to Book (PBR) Free Cash Flow (FCF)
Top Consensus
Consensus composite Analyst Opinion Target price Opinion Divergences Estimates Revisions Analyst coverage
Technical Analysis Rankings
Daily Breakouts Weekly Breakouts
Top ranking ESG
Environment
Islamic Finance Paris Agreement
Stock Screener Home
Investment Themes
The Vegan Market Private Equity
Place your bets Gold and Silver
Technical Rankings
Oversold stocks Overbought stocks Close to resistance Close to support Accumulation Phases Most volatile stocks
Fundamental Rankings
Top Investor Rating Top Trading Rating Top Consensus
Top Dividends Low valuations
My Screeners
All my stocks
Virtual Portfolios
MarketScreener tools
Stock Screener
Expert tools
Stock Screener PRO Portfolio Creator Event Screener Dynamic Chart Company calendar Economic calendar Currency Converter
Our Services
Our subscriptions Our Stock Picks Stock Screener Thematic Investment Lists
MarketScreener Portfolios
European Portfolio USA Portfolio Asian Portfolio Switch edition
QIAGEN N.V.
Add to a list
Qiagen N.V.
NL0015002SN0
Biotechnology & Medical Research
Market Closed -
Other stock markets
04:00:02 2026-04-21 pm EDT
5-day change
1st Jan Change
Qiagen N.V Showcases New Sample To Insight Solutions For Complex Oncology Applications
Qiagen Expands Into Bloodstream Infection Testing With New Panel
Technical Analysis
Static Chart
Total Return chart
Sector Chart
Comparison Chart
Relative Strength Chart
Analyst Reco.
Transcripts
Press Releases
Official Publications
Other languages
MarketScreener Editorial Features
MarketScreener Strategies
Trading Ideas
Share ownership
Connections
Analysts' Forecasts
Income Statement
Balance Sheet
Financial Ratios
Business Segments
Valuation ratios
Analysts' Opinion
Estimates Revisions
Sector performance
Sector valuations
Sector dividends
Financial comparisons
Sector ratings
Sector consensus
Sector revisions
Analyst Reco.
Transcripts
Press Releases
Official Publications
Other languages
MarketScreener Editorial Features
MarketScreener Strategies
Trading Ideas
QIAGEN NV : Gets a Buy rating from Jefferies
Published on 11/20/2025 at 01:59 am EST
MarketScreener with dpa-AFX Analyser
QIAGEN N.V.
Jefferies is positive on the stock with a Buy rating.
© MarketScreener with dpa-AFX Analyser -
Latest news about Qiagen N.V.
Qiagen N.V Showcases New Sample To Insight Solutions For Complex Oncology Applications
Qiagen Expands Into Bloodstream Infection Testing With New Panel
Qiagen N.V. Expands into Bloodstream Infection Syndromic Testing with New Rapid QIAstat-Dx Panel
QIAGEN NV :Barclays is less optimistic
Barclays Downgrades QIAGEN to Equalweight From Overweight, Adjusts Price Target to $44 From $48
Bruker Corporation Announces Appointment of Thierry L. Bernard to Its Board of Directors, Effective April 1, 2026
AlphaValue/Baader Europe Upgrades Qiagen to Buy
Qiagen N.V. Highlights Newly Published Data Supporting Efficacy of QuantiFERON for Tb Prevention
Frankfurt Market Close: Dax continues to slide - Risk aversion persists amid oil concerns
Wall Street Clings to Hope
Deutsche Bank Upgrades Qiagen to Buy Rating, Lifts PT
Analyst recommendations: Adobe, Oracle, Dow, Him & Hers, Whirlpool…
QIAGEN NV :Upgraded to Buy by Deutsche Bank
Qiagen receives U.S. clearance for gastrointestinal panels on fully automated Qiastat-Dx Rise syndromic testing system
QIAGEN Gets US FDA Clearance for Gastrointestinal Panels on Automated Syndromic Platform
Chart Qiagen N.V.
QGEN: Dynamic Chart
Company Profile
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
Biotechnology & Medical Research
More about the company
Income Statement and Estimates
More financial data
Analysis / Opinion
Qiagen: 2025 ended positively, entering 2026 with confidence
February 06, 2026 at 09:42 am EST
More analyses
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
More Ratings
Analysts' Consensus
Mean consensus
Number of Analysts
Last Close Price
Average target price
Spread / Average Target
EPS Estimates
Revisions to estimates
Quarterly revenue - Rate of surprise
Company calendar
My Watchlist
More Rankings
More Rankings
Currency / Forex
Commodities
Cryptocurrencies
Interest Rates
Stock Market Stock Market News QIAGEN NV :Gets a Buy rating from Jefferies
Best financial
More than 20 years at your side
+ 1,300,000
Quick & easy cancellation
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
Legal information
Cookie settings
MarketScreener Blog
Copyright © 2026 Surperformance SAS. All rights reserved.
Stock quotes are provided by Factset, Morningstar and S&P Capital IQ
The best tools reserved for subscribers to boost the performance of your investments!
Optimize my profits
Optimize my profits
Select your edition All financial news and data tailored to specific country editions
NORTH AMERICA
United-States
MIDDLE EAST
Saudi Arabia United Arab Emirates
Deutschland
United Kingdom